May 28, 2015 Arno Therapeutics Announces AR-12 Antiviral Data Against Multiple Hemorrhagic Fevers Published Online in Antiviral Research
May 7, 2015 Arno Therapeutics Receives USPTO Notice of Allowance for Two Important Patents Covering Lead Compound Onapristone
May 5, 2015 Capricor Therapeutics to Hold First Quarter 2015 Business Update and Financial Results Conference Call on May 12, 2015 at 4:30 p.m. EDT
April 30, 2015 Arno Therapeutics Receives European Orphan Drug Designation for AR-12 to Treat Two Infectious Diseases
April 29, 2015 Arno Therapeutics to Present Three Posters Supporting Onapristone Development at ASCO Annual Meeting 2015
April 22, 2015 Capricor Granted FDA Orphan Drug Designation for Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy
April 21, 2015 Kite Pharma Commends Honors Conferred to Drs. Owen Witte and Steven A. Rosenberg at the 2015 American Association for Cancer Research (AACR) Annual Meeting
April 21, 2015 Arno Therapeutics to Present Promising Data from Phase I Trial of Onapristone at AACR Annual Meeting 2015
April 13, 2015 Arno Therapeutics Announces Three Poster Presentations at Upcoming AACR Annual Meeting 2015
April 8, 2015 Capricor Completes Enrollment of Initial Phase of DYNAMIC Clinical Trial of Cardiosphere-Derived Cell Therapy for Treatment of Advanced Heart Failure
April 6, 2015 Kite Pharma Announces Publication in Science of Cancer Immunotherapy Articles Authored by Lead Collaborators at the National Cancer Institute and the Netherlands Cancer Institute
March 31, 2015 Capricor Therapeutics Completes Enrollment of Phase II Clinical Trial for Cenderitide to Treat Heart Failure
March 25, 2015 Kite Pharma to Report Fourth Quarter and Full Year 2014 Financial Results on March 26th, 2015
March 24, 2015 New Data Supporting Arno Therapeutics’ HDAC inhibitor AR-42 Published in The Journal of Urology
March 23, 2015 Capricor Therapeutics to Present at 3rd Annual Regen Med Investor Day on March 25, 2015 in New York
March 18, 2015 Capricor Therapeutics Reports Fourth Quarter and Full Year 2014 Financial & Business Highlights
March 17, 2015 Kite Pharma Strengthens Its T Cell Receptor (TCR) Cancer Gene Therapy Platform Through Acquisition of T-Cell Factory B.V. (TCF(TM))
March 12, 2015 Capricor Therapeutics to Hold Fourth Quarter 2014 Business Update Conference Call on March 18, 2015 at 4:30 p.m. EDT
